AB0419 Real world use of tofacitinib in rheumatoid arthritis: data from latin america

Autor: LJ Elizondo, Marcia Pinheiro, L Gόrriz, D. Ponce de Leon, LF Medina, Emilce Edith Schneeberger, Rdn Giorgi, JC Sarmiento-Monroy, A Salas, B Garro, RD Mantilla, H. Madariaga, JB Zacariaz

Publikováno v: Abstracts Accepted for Publication.

Background Tofacitinib is an oral JAK inhibitor for the treatment of RA. Tofacitinib can be given as monotherapy or with csDMARDs. Published data on real world (RW) tofacitinib use in Latin America (LA) are limited. We characterise the patient (pt) p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::932e266cda497e3db8372b19af9368c1
https://doi.org/10.1136/annrheumdis-2017-eular.1607

Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.

Autor: Gómara MJ; Unit of Synthesis and Biomedical Applications of Peptides, Institut de Química Avançada de Catalunya, Consejo Superior de Investigaciones Científicas (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain., Sarmiento-Monroy JC; Department of Rheumatology, Hospital Clínic of Barcelona, 08036 Barcelona, Spain., Castellanos-Moreira R; Department of Rheumatology, Hospital Clínic of Barcelona, 08036 Barcelona, Spain., Gómez-Puerta JA; Department of Rheumatology, Hospital Clínic of Barcelona, 08036 Barcelona, Spain., Sanmartí R; Department of Rheumatology, Hospital Clínic of Barcelona, 08036 Barcelona, Spain., Haro I; Unit of Synthesis and Biomedical Applications of Peptides, Institut de Química Avançada de Catalunya, Consejo Superior de Investigaciones Científicas (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 03; Vol. 25 (19). Date of Electronic Publication: 2024 Oct 03.

Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice.

Autor: Alascio L; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Azuaga-Piñango AB; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Frade-Sosa B; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Sarmiento-Monroy JC; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Ponce A; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Farietta S; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Gómez-Puerta JA; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Sanmartí R; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Cañete JD; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain., Ramírez J; Arthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Villarroel Street, 170, 08036 Barcelona, Spain.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Jul 30; Vol. 14 (15). Date of Electronic Publication: 2024 Jul 30.

Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study.

Autor: Frade-Sosa B; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Ponce A; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Ruiz-Ortiz E; Department of Immunology-CDB, Hospital Clinic of Barcelona, Barcelona, Barcelona, Spain., De Moner N; Department of Immunology-CDB, Hospital Clinic of Barcelona, Barcelona, Barcelona, Spain., Gómara MJ; Unit of Synthesis and Biomedical Applications of Peptides, Institute for Advanced Chemistry of Catalonia. Consejo Superior de Investigaciones Científicas (IQAC-CSIC), Barcelona, Spain., Azuaga AB; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Sarmiento-Monroy JC; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Morlà R; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Ruiz-Esquide V; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Macías L; Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, Barcelona, Spain., Sapena N; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Tobalina L; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Ramirez J; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Cañete JD; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Yague J; Department of Immunology-CDB, Hospital Clinic of Barcelona, Barcelona, Barcelona, Spain., Auge JM; Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, Barcelona, Spain., Gomez-Puerta JA; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain., Viñas O; Department of Immunology-CDB, Hospital Clinic of Barcelona, Barcelona, Barcelona, Spain., Haro I; Unit of Synthesis and Biomedical Applications of Peptides, Institute for Advanced Chemistry of Catalonia. Consejo Superior de Investigaciones Científicas (IQAC-CSIC), Barcelona, Spain., Sanmarti R; Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain. sanmarti@clinic.cat.

Publikováno v: Rheumatology and therapy [Rheumatol Ther] 2024 Jun; Vol. 11 (3), pp. 501-521. Date of Electronic Publication: 2024 Mar 02.

Assessment and personalised advice for fatigue in systemic lupus erythematosus using an innovative digital tool: the Lupus Expert system for the Assessment of Fatigue (LEAF) study.

Autor: Kawka L; Department of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Sarmiento-Monroy JC; Department of Rheumatology, Hospital Clinic, Barcelona, Spain., Mertz P; Department of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Pijnenburg L; Department of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Rinagel M; Department of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Ugarte-Gil MF; Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Cientifica del Sur, Lima, Peru.; Rheumatology Department, Hospital Guillermo Almenara Irigoyen, EsSalud, Lima, Peru., Geneton S; Department of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Blaess J; Department of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Piga M; Department of Medical Sciences and Public health, University of Cagliari, Cagliari, Italy., Arnaud L; Department of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France laurent.arnaud@chru-strasbourg.fr.; INSERM UMR-S 1109, Immuno-rhumatologie moléculaire, Strasbourg, France.

Publikováno v: RMD open [RMD Open] 2023 Dec 06; Vol. 9 (4). Date of Electronic Publication: 2023 Dec 06.